About BLCM

Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. Bellicum is using its proprietary Chemical Induction of Dimerization (CID) technology platform to engineer and control components of the immune system. Bellicum is developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), and CAR T and TCR cell therapies.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

BLCM is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 104.2 M 1.04202E+08 2,017 2017 0.0% 1.49961E-05 5 K 5060
UWM ProShares Ultra Russell2000 182.3 M 1.82294E+08 2,017 2017 0.0% 2.24505E-05 9 K 9080
VHT Vanguard Health Care ETF 9.4 B 9.400001E+09 361 361 0.0% 2E-05 220 K 220051
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.01% 8E-05 23 K 23264
VXF Vanguard Extended Market ETF 6.8 B 6.8E+09 3,242 3242 0.0% 3E-05 193 K 192681
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.0% 2.79108E-05 45 K 44593
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.6 B 1.85536E+10 3,550 3550 0.0% 0 123 K 123364
IWC iShares Microcap ETF 914.4 M 9.14374E+08 1,451 1451 0.03% 0.0003 315 K 314652
IWM iShares Russell 2000 ETF 43.0 B 4.29906E+10 2,006 2006 0.01% 0.0001 2.7 M 2668580
IWN iShares Russell 2000 Value ETF 9.2 B 9.24826E+09 1,370 1370 0.0% 0 394 K 394479
IWO iShares Russell 2000 Growth ETF 9.1 B 9.14116E+09 1,239 1239 0.01% 0.0001 760 K 760201
IWV iShares Russell 3000 ETF 9.8 B 9.77316E+09 2,956 2956 0.0% 0 31 K 30911

Wait, Before You Leave...